SCHEMBL8895951

SCHEMBL8895951

CCc1cc[c]c(OC)c1OC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8405285 0.85 HMGCR (0.34)
SCHEMBL2439840 0.82 MAPT (0.37)
SCHEMBL15063533 0.80 PTGS2 (0.32) PTGS2
SCHEMBL456728 0.80 PDE3B (0.31)
SCHEMBL455800 0.73 GABRA1 (0.37)
SCHEMBL10345470 0.73 NCOA1 (0.36)
SCHEMBL8196392 0.72 KDM4E (0.32)
SCHEMBL77640 0.72 CA9 (0.35) PTGS2
SCHEMBL22575947 0.71 CA2 (0.35)
SCHEMBL28366984 0.71 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5656648-A TREATMENT OF PATHOLOGIES NECESSITATING STIMULATION OF CHOLECYSTOKININ-A RECEPTORS BY TOTAL OR PARTIAL AGONIST EFFECT SANOFI (FR) 1997-08-12 US claimed